608 related articles for article (PubMed ID: 28292019)
1. Carcinogenesis mechanisms of Fusobacterium nucleatum.
Gholizadeh P; Eslami H; Kafil HS
Biomed Pharmacother; 2017 May; 89():918-925. PubMed ID: 28292019
[TBL] [Abstract][Full Text] [Related]
2. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
[TBL] [Abstract][Full Text] [Related]
3. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
4. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum.
Liu J; Hsieh CL; Gelincik O; Devolder B; Sei S; Zhang S; Lipkin SM; Chang YF
J Proteomics; 2019 Mar; 195():125-137. PubMed ID: 30634002
[TBL] [Abstract][Full Text] [Related]
5. Fusobacterium nucleatum and oral cancer: a critical review.
McIlvanna E; Linden GJ; Craig SG; Lundy FT; James JA
BMC Cancer; 2021 Nov; 21(1):1212. PubMed ID: 34774023
[TBL] [Abstract][Full Text] [Related]
6. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer.
Wang N; Fang JY
Trends Microbiol; 2023 Feb; 31(2):159-172. PubMed ID: 36058786
[TBL] [Abstract][Full Text] [Related]
7.
Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
[TBL] [Abstract][Full Text] [Related]
8. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
[TBL] [Abstract][Full Text] [Related]
9.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
10. The role of
Sun CH; Li BB; Wang B; Zhao J; Zhang XY; Li TT; Li WB; Tang D; Qiu MJ; Wang XC; Zhu CM; Qian ZR
Chronic Dis Transl Med; 2019 Sep; 5(3):178-187. PubMed ID: 31891129
[TBL] [Abstract][Full Text] [Related]
11. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
[TBL] [Abstract][Full Text] [Related]
12. The Role of
Pignatelli P; Nuccio F; Piattelli A; Curia MC
Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764202
[TBL] [Abstract][Full Text] [Related]
13. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin.
Rubinstein MR; Wang X; Liu W; Hao Y; Cai G; Han YW
Cell Host Microbe; 2013 Aug; 14(2):195-206. PubMed ID: 23954158
[TBL] [Abstract][Full Text] [Related]
14. The ways Fusobacterium nucleatum translocate to breast tissue and contribute to breast cancer development.
Guo X; Yu K; Huang R
Mol Oral Microbiol; 2024 Feb; 39(1):1-11. PubMed ID: 38171827
[TBL] [Abstract][Full Text] [Related]
15. Fusobacterium nucleatum - Friend or foe?
Stokowa-Sołtys K; Wojtkowiak K; Jagiełło K
J Inorg Biochem; 2021 Nov; 224():111586. PubMed ID: 34425476
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a novel adhesin unique to oral fusobacteria.
Han YW; Ikegami A; Rajanna C; Kawsar HI; Zhou Y; Li M; Sojar HT; Genco RJ; Kuramitsu HK; Deng CX
J Bacteriol; 2005 Aug; 187(15):5330-40. PubMed ID: 16030227
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
[TBL] [Abstract][Full Text] [Related]
18. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium.
Brennan CA; Garrett WS
Nat Rev Microbiol; 2019 Mar; 17(3):156-166. PubMed ID: 30546113
[TBL] [Abstract][Full Text] [Related]
19.
Casasanta MA; Yoo CC; Udayasuryan B; Sanders BE; Umaña A; Zhang Y; Peng H; Duncan AJ; Wang Y; Li L; Verbridge SS; Slade DJ
Sci Signal; 2020 Jul; 13(641):. PubMed ID: 32694172
[No Abstract] [Full Text] [Related]
20. Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance.
Ye C; Liu X; Liu Z; Pan C; Zhang X; Zhao Z; Sun H
Cancer Biol Ther; 2024 Dec; 25(1):2306676. PubMed ID: 38289287
[No Abstract] [Full Text] [Related]
[Next] [New Search]
